Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Br J Nutr ; 123(10): 1117-1126, 2020 05 28.
Artigo em Inglês | MEDLINE | ID: mdl-32077406

RESUMO

The study of polyphenols' effects on health has been gaining attention lately. In addition to reacting with important enzymes, altering the cell metabolism, these substances can present either positive or negative metabolic alterations depending on their consumption levels. Naringenin, a citrus flavonoid, already presents diverse metabolic effects. The objective of this work was to evaluate the effect of maternal naringenin supplementation during pregnancy on the tricarboxylic acid cycle activity in offspring's cerebellum. Adult female Wistar rats were divided into two groups: (1) vehicle (1 ml/kg by oral administration (p.o.)) or (2) naringenin (50 mg/kg p.o.). The offspring were euthanised at 7th day of life, and the cerebellum was dissected to analyse citrate synthase, isocitrate dehydrogenase (IDH), α-ketoglutarate dehydrogenase (α-KGDH) and malate dehydrogenase (MDH) activities. Molecular docking used SwissDock web server and FORECASTER Suite, and the proposed binding pose image was created on UCSF Chimera. Data were analysed by Student's t test. Naringenin supplementation during pregnancy significantly inhibited IDH, α-KGDH and MDH activities in offspring's cerebellum. A similar reduction was observed in vitro, using purified α-KGDH and MDH, subjected to pre-incubation with naringenin. Docking simulations demonstrated that naringenin possibly interacts with dehydrogenases in the substrate and cofactor binding sites, inhibiting their function. Naringenin administration during pregnancy may affect cerebellar development and must be evaluated with caution by pregnant women and their physicians.


Assuntos
Cerebelo/enzimologia , Ciclo do Ácido Cítrico/efeitos dos fármacos , Suplementos Nutricionais , Flavanonas/administração & dosagem , Fenômenos Fisiológicos da Nutrição Materna , Animais , Citrato (si)-Sintase/efeitos dos fármacos , Feminino , Isocitrato Desidrogenase/efeitos dos fármacos , Complexo Cetoglutarato Desidrogenase/efeitos dos fármacos , Malato Desidrogenase/efeitos dos fármacos , Simulação de Acoplamento Molecular , Gravidez , Ratos , Ratos Wistar
2.
Biochemistry (Mosc) ; 70(7): 726-9, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16097935

RESUMO

The question of regulation of alpha-ketoglutarate dehydrogenase complex (KGDHC) has been considered in the biochemical literature very rarely. Moreover, such information is not usually accurate, especially in biochemical textbooks. From the mini-review of research works published during the last 25 years, the following basic view is clear: a) animal KGDHC is very sensitive to ADP, P(i), and Ca2+; b) these positive effectors increase manifold the affinity of KGDHC to alpha-ketoglutarate; c) KGDHC is inhibited by ATP, NADH, and succinyl-CoA; d) the ATP effect is realized in several ways, probably mainly via opposition versus ADP activation; e) NADH, besides inhibiting dihydrolipoamide dehydrogenase component competitively versus NAD+, decreases the affinity of alpha-ketoglutarate dehydrogenase to substrate and inactivates it; f) thioredoxin protects KGDHC from self-inactivation during catalysis; g) bacterial and plant KGDHC is activated by AMP instead of ADP. These main effects form the basis of short-term regulation of KGDHC.


Assuntos
Metabolismo Energético/fisiologia , Complexo Cetoglutarato Desidrogenase/metabolismo , Difosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Trifosfato de Adenosina/farmacologia , Animais , Cálcio/metabolismo , Humanos , Complexo Cetoglutarato Desidrogenase/antagonistas & inibidores , Complexo Cetoglutarato Desidrogenase/efeitos dos fármacos , NAD/metabolismo , NAD/farmacologia
3.
Chem Res Toxicol ; 13(8): 749-60, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10956063

RESUMO

The major initial product of the oxidation of norepinephrine (NE) in the presence of L-cysteine is 5-S-cysteinylnorepinephrine which is then further easily oxidized to the dihydrobenzothiazine (DHBT) 7-(1-hydroxy-2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1, 4-benzothiazine-3-carboxylic acid (DHBT-NE-1). When incubated with intact rat brain mitochondria, DHBT-NE-1 evokes rapid inhibition of complex I respiration without affecting complex II respiration. DHBT-NE-1 also evokes time- and concentration-dependent irreversible inhibition of NADH-coenzyme Q(1) (CoQ(1)) reductase, the pyruvate dehydrogenase complex (PDHC), and alpha-ketoglutarate dehydrogenase (alpha-KGDH) when incubated with frozen and thawed rat brain mitochondria (mitochondrial membranes). The time dependence of the inhibition of NADH-CoQ(1) reductase, PDHC, and alpha-KGDH by DHBT-NE-1 appears to be related to its oxidation, catalyzed by an unknown component of the inner mitochondrial membrane, to electrophilic intermediates which bind covalently to active site cysteinyl residues of these enzyme complexes. The latter conclusion is based on the ability of glutathione to block inhibition of NADH-CoQ(1) reductase, PDHC, and alpha-KGDH by scavenging electrophilic intermediates, generated by the mitochondrial membrane-catalyzed oxidation of DHBT-NE-1, forming glutathionyl conjugates, several of which have been isolated and spectroscopically identified. The possible implications of these results to the degeneration of neuromelanin-pigmented noradrenergic neurons in the locus ceruleus in Parkinson's disease are discussed.


Assuntos
Inibidores Enzimáticos/farmacologia , Mitocôndrias/efeitos dos fármacos , Complexos Multienzimáticos/efeitos dos fármacos , Norepinefrina/análogos & derivados , Doença de Parkinson/metabolismo , Tiazinas/farmacologia , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/enzimologia , Encéfalo/metabolismo , Cromatografia Líquida de Alta Pressão , Complexo III da Cadeia de Transporte de Elétrons/antagonistas & inibidores , Complexo III da Cadeia de Transporte de Elétrons/efeitos dos fármacos , Inibidores Enzimáticos/síntese química , Complexo Cetoglutarato Desidrogenase/antagonistas & inibidores , Complexo Cetoglutarato Desidrogenase/efeitos dos fármacos , Masculino , Mitocôndrias/enzimologia , Complexos Multienzimáticos/antagonistas & inibidores , Norepinefrina/metabolismo , Oxirredução , Complexo Piruvato Desidrogenase/antagonistas & inibidores , Complexo Piruvato Desidrogenase/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
4.
Biochem Mol Biol Int ; 37(1): 101-6, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8653071

RESUMO

The purified 2-oxoglutarate dehydrogenase complex (OGDC) from the European bison heart was near saturated with endogenous bound thiamine pyrophosphate (TPP). Exogenous TPP added to the full OGDC reaction medium decreased S0.5 for 2-oxoglutarate approximately 2.6-fold without any notable change in the maximum reaction rate. The TPP effect was observed in the presence of 1 mM ADP which alone is a strong positive allosteric effector of OGDC. At an unsaturating 2-oxoglutarate concentration the A50 value for TPP was approximately 0.05 mM. The ADP-like action of exogenous TPP was also found in the 2-oxoglutarate dehydrogenase (E1) reaction, determined in the presence of 2,6-dichlorophenoloindophenol as an electron acceptor.


Assuntos
Complexo Cetoglutarato Desidrogenase/efeitos dos fármacos , Complexo Cetoglutarato Desidrogenase/metabolismo , Miocárdio/enzimologia , Tiamina Pirofosfato/metabolismo , Tiamina Pirofosfato/farmacologia , Difosfato de Adenosina/metabolismo , Difosfato de Adenosina/farmacologia , Animais , Bison , Cálcio/metabolismo , Cálcio/farmacologia , Relação Dose-Resposta a Droga , Cinética
5.
Biochem J ; 303 ( Pt 2): 461-5, 1994 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-7980405

RESUMO

The regulatory properties of NAD(+)-isocitrate dehydrogenase and oxoglutarate dehydrogenase in extracts of yeast and rat heart mitochondria were studied under identical conditions. Yeast NAD(+)-isocitrate dehydrogenase exhibits a low K0.5 for isocitrate and is activated by AMP and ADP, but is insensitive to ATP and Ca2+. In contrast, the rat heart NAD(+)-isocitrate dehydrogenase was insensitive to AMP, but was activated by ADP and by Ca2+ in the presence of ADP or ATP. Both yeast and rat heart oxoglutarate dehydrogenase were stimulated by ADP, but only the heart enzyme was activated by Ca2+. All the enzymes studied were activated by decreases in pH, but to differing extents. The effects of Ca2+, adenine nucleotides and pH were through K0.5 for isocitrate or 2-oxoglutarate. These observations are discussed with reference to the deduced amino acid sequences of the constituent subunits of the enzymes, where they are available.


Assuntos
Nucleotídeos de Adenina/farmacologia , Cálcio/farmacologia , Isocitrato Desidrogenase/efeitos dos fármacos , Complexo Cetoglutarato Desidrogenase/efeitos dos fármacos , Mitocôndrias Cardíacas/enzimologia , Saccharomyces cerevisiae/enzimologia , Difosfato de Adenosina/farmacologia , Monofosfato de Adenosina/farmacologia , Trifosfato de Adenosina/farmacologia , Sequência de Aminoácidos , Animais , Sequência Consenso , Concentração de Íons de Hidrogênio , Isocitrato Desidrogenase/química , Isocitrato Desidrogenase/metabolismo , Complexo Cetoglutarato Desidrogenase/metabolismo , Ácidos Cetoglutáricos/farmacologia , Cinética , Masculino , Dados de Sequência Molecular , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA